Company profile
Ticker
CPXX
Exchange
Employees
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
13 Feb 18
15-12B/A
Securities registration termination (amended)
2 Aug 16
EFFECT
Notice of effectiveness
1 Aug 16
POS AM
Prospectus update (post-effective amendment)
27 Jul 16
EFFECT
Notice of effectiveness
25 Jul 16
15-12B
Securities registration termination
22 Jul 16
25-NSE
Exchange delisting
12 Jul 16
8-K
Termination of a Material Definitive Agreement
12 Jul 16
POS AM
Prospectus update (post-effective amendment)
12 Jul 16
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Jul 16
Latest ownership filings
SC 13G/A
Celator Pharmaceuticals Inc
15 Feb 17
SC 13G/A
Celator Pharmaceuticals Inc
14 Feb 17
SC 13G/A
Celator Pharmaceuticals Inc
30 Jan 17
SC 13D/A
Celator Pharmaceuticals Inc
15 Jul 16
4
Richard S Kollender
13 Jul 16
4
JOSEPH A MOLLICA
12 Jul 16
4
NICOLE VITULLO
12 Jul 16
4
MICHAEL R DOUGHERTY
12 Jul 16
4
Scott Thomas Jackson
12 Jul 16
4
JEAN-PIERRE BIZZARI
12 Jul 16
Institutional ownership, Q3 2019
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|